Federal grants to Immunochem Therapeutics LLC
Immunochem Therapeutics LLC in Auburndale, Massachusetts received $4.9 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Aging Research, with $3.0 million. In fiscal 2025 it was awarded $1.2 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$4.9 million
- Awards3
- Awarded in FY 2025$1.2 million
- Largest award$3.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $1.2 million |
| FY 2022 | 2 | $1.2 million |
| FY 2023 | 0 | $0 |
| FY 2024 | 1 | $1.2 million |
| FY 2025 | 1 | $1.2 million |
Programs that fund Immunochem Therapeutics LLC
| Program | Awards | Amount |
|---|---|---|
| Aging Research | 1 | $3.0 million |
| Cancer Treatment Research | 1 | $1.5 million |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 1 | $394,683 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $4.9 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Development of a novel anti-neuroinflammatory experimental therapeutic for epilepsy and alzheimer's risk - abstract alzheimer’s disease and epilepsy are common age-related cns disorders. Both alzheimer’s disease and epilepsy are more frequent in the elderly compared to any other age groups, and a hi | Aging Research | August 31, 2021 | $3.0 million |
| Mitigation of radiation therapy induced neuroinflammation and cognitive dysfunction - project summary cognitive decline and deterioration of long-term cognitive performance are major side effects of cns cancer treatment. Brain metastases are the most common cns malignancies and a common cause of mor | Cancer Treatment Research | August 20, 2021 | $1.5 million |
| Novel anti-neuroinflammatory drug for aneurysmal subarachnoid hemorrhage (ASAH) - abstract nontraumatic (aneurysmal) subarachnoid hemorrhage (ASAH) is one of the most dangerous forms of stroke, with almost half of victims dying within the first month after diagnosis, and a half of the survivors beco | Extramural Research Programs in the Neurosciences and Neurological Disorders | September 18, 2022 | $394,683 |
Questions people ask
How much federal grant money does Immunochem Therapeutics LLC get?
$4.9 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Immunochem Therapeutics LLC the most?
The Department of Health and Human Services, with $4.9 million in 3 awards.
What is Immunochem Therapeutics LLC's largest federal grant?
$3.0 million under Aging Research, with its first action in the period on August 31, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Immunochem Therapeutics LLC?
Its largest are Aging Research, Cancer Treatment Research and Extramural Research Programs in the Neurosciences and Neurological Disorders.
Other grant recipients in Auburndale
Largest federal grant recipients in Massachusetts · Federal grants in Massachusetts